This Genomics ETF Has Some Coronavirus Vaccine Leverage
February 05, 2020 at 10:56 AM EST
The race is on to find a cure for the deadly coronavirus and that competition could benefit some ETFs, including the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). ARKG includes companies that merge healthcare with technology and capitalize on the revolution in genomic sequencing. These...